Overzicht gehonoreerde projecten Open Ronde 6

De indeling van de projecten is gebaseerd op de vastgestelde lacunes. Zij zijn tevens ingedeeld per bijzondere patiëntengroep. Hierdoor staan enkele projecten dubbel vermeld.

In de komende tijd verschijnt er uitgebreidere informatie over deze projecten op hun eigen projectpagina. De links naar deze projectpagina's zullen worden toegevoegd zodra dit mogelijk is. 

• Chronotherapy with aspirin for reduction of cardiovascular disease (TImE ASPIRIN)

• Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP (OPTIC trial)

• MYPP-trial: A multicenter double-blind placebo-controlled randomized trial to prevent pregnancy complications of women with polycystic ovary syndrome using myo-inositol.

• Pharmacogenetics to improve personalized antidepressant dosing in patients with severe depression; a randomized controlled trial using Tricyclic Antidepressants

• Tailored treatment of functional dyspepsia with nortriptyline: a multi-center double-blind placebo-controlled trial (TENDER)

• Genome-wide association study to discover novel genetic variants related to the onset of severe toxicity following fluoropyrimidine use: beyond DPD.

• The predictive value of the gut microbiota composition in Clostridium difficile infection for customization of treatment

• Individualized PeMetRexed dOsing in lung cancER and mesothelioma patients to improVE treatment response and allow treatment of patients with impaired renal function – The IMPROVE study (previous acronym: PROPER study).

• Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support program

• Resistant HYpertension: MEasure to ReaCh Targets (RHYME-RCT)

• Thuis-monitoren bij Idiopathische Long Fibrose; beter gebruik fibrose-remmers, betere kwaliteit van leven

• CHECkUP: Control in the Hospital by Extensive Clinical rules for Unplanned hospitalisations in elderly Patients.

• Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?

Over het gebruik van geneesmiddelen door kinderen, ouderen, zwangeren, mensen met zeldzame aandoeningen en ter voorkoming van antimicrobiële resistentie is meer wetenschappelijke onderbouwde kennis nodig.

• Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support program

• CHECkUP: Control in the Hospital by Extensive Clinical rules for Unplanned hospitalisations in elderly Patients.

• Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?

• MYPP-trial: A multicenter double-blind placebo-controlled randomized trial to prevent pregnancy complications of women with polycystic ovary syndrome using myo-inositol.